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A B S T R A C T A rabbit model for the diabetic
pregnancy was used to investigate the etiology of
delayed pulmonary maturation observed in infants of
diabetic mothers. Pregnant rabbit does were made
glucose intolerant and insulinopenic by injection of
alloxan, a pancreatic 8-cell cytotoxin. At 28 d (term
- 31 d) fetuses of these animals were hyperglycemic,
but were not hyperinsulinemic and did not demonstrate
tissue overgrowth. Fetal pulmonary maturity was
assessed by measurement of pressure-volume relation-
ships on the fetal lungs. Fetuses of glucose-intolerant
does demonstrated less retention of air on deflation.
Phospholipid components of pulmonary surfactant
were assayed on fluid obtained from lavage of the fetal
lungs. Levels of disaturated phosphatidylcholine (per-
cent total-lavage phospholipids) were diminished in
fetuses of glucose-intolerant does compared to control
fetuses (20.5+4.2 vs. 38.0+4.3%; P < 0.01). Lecithin/
sphingomyelin ratios were similar in both groups and
phosphatidylglycerol was not detected in either group.
There was a direct correlation between the percentage
of alveolar disaturated phosphatidylcholine and reten-
tion of air on lung deflation. These findings suggest that
in this model pulmonary instability was a result of
diminished alveolar disaturated phosphatidylcholine,
and this diminution did not result from fetal hyper-
insulinemia.
INTRODUCTION
The infant ofthe diabetic mother (IDM)l is predisposed
to life-threatening aberrations in physiology. An in-
creased risk for the development of the respiratory
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1 Abbreviations used in this paper: DSPC, disaturated
phosphatidylcholine; IDM, infant ofthe diabetic mother; LUS,
lecithin to sphingomyelin; PG, phosphatidylglycerol; RDS,
respiratory distress syndrome.
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distress syndrome (RDS) is one manifestation of these
aberrations. Gellis and Hsia (1) originally reported the
association of maternal diabetes and RDS. Their
findings were confirmed in a more recent report by
Robert and co-workers (2) who demonstrated that RDS
occurred 5.6 times more frequently in IDM than in
infants of nondiabetics.
Diminished alveolar surfactant is the principal cause
of RDS in premature infants (3). Although surfactant is
composed of a variety of substances, its phospholipid
content has attracted the most research interest. Certain
phospholipids, particularly the lecithins, have the
capacity to achieve the low surface tensions necessary
to stabilize alveoli in the newborn lung. Therefore,
estimation of fetal pulmonary lecithin production by
measurement of the lecithin to sphingomyelin ratio in
amniotic fluid is used as an index of fetal pulmonary
maturity (4). Although this measure is highly predictive
of lung maturation in normal pregnancies, it is pe-
culiarly unreliable in the diabetic pregnancy (5). This
finding suggests that maternal diabetes interferes with
fetal pulmonary maturation without affecting total
lecithin synthesis.
Disaturated lecithin (disaturated phosphatidylcho-
line: DSPC) is the lecithin with the greatest capacity to
lower surface tension (6) and quantitatively is the
predominate lecithin in pulmonary surfactant (7). It is
possible that the relative proportion of DSPC is
diminished in pulmonary surfactant of the IDM
without change in total lecithin. To investigate the
possibility that alterations exist in pulmonary phospho-
lipid content in the IDM, we have used the alloxan-
treated pregnant rabbit as a model for diabetes during
pregnancy (8, 9). Fetuses of glucose-intolerant rabbit
does were found to have changes in pulmonary
dynamics consistent with the pulmonary immaturity
seen in IDM, and these changes were associated with
diminished alveolar DSPC.
METHODS
Animals and experimental design. New Zealand white
rabbit does were bred with the time ofmating known to within
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3 h. Diabetes was induced by intravenous injection of alloxan
(2,4,5,6-tetraoxypyrimidine; 5,6-dioxyuracil; Sigma Chemical
Co., St. Louis, Mo.), a pancreatic p-cell cytotoxin. Does were
treated with a total dose of between 60 and 130 mg/kg: half
given at 48 h after mating and the remainder at 72 h after
mating. Of the 62 mated rabbits that were injected with
alloxan, 13 were hyperglycemic (serum glucose > 150 mg/dl)
during gestation and were pregnant at sacrifice. Of the
remaining 49 rabbits, 26 died after injection. 17 of the
surviving rabbits remained euglycemic. Six of the injected,
nonstudy animals developed glucose intolerance, two deliv-
ered spontaneously before 28 d gestation, and four were not
pregnant at sacrifice. 10 control animals were mated and
studied concurrently. Maternal blood was collected weekly
until sacrifice. Immediately after collection the blood was
chilled at 40C and after clot formation, the serum was separated
and frozen.
Control and alloxan-treated does were sacrificed at 28 d
gestation (term - 31 d) by intravenous injection of 300 mg of
pentobarbital. The fetuses were immediately delivered within
their amniotic sacs by hysterotomy and injected intraperitone-
ally with 30 mg ofpentobarbital before removal ofthe amniotic
membranes. Though an occasional animal gasped, none
breathed air before death. Alternate pups were exsanguinated
by direct cardiac puncture as soon as possible (<10 min). The
serum was chilled, separated, and stored. The crown-rump
length and weight of these pups were recorded, and their
lungs, liver, heart, brain, kidneys, and placentae were
removed and weighed.
Pulmonary function measurements. Quasi-static pressure/
volume measurements were performed on the lungs of the
remaining pups by the technique ofKotas and Avery (10). After
weighing and measuring of the pup, the trachea was cannu-
lated with a polyethylene catheter (Clay-Adams, Div., Becton,
Dickinson & Co., Parsippany, N. J.) with the lungs remaining
in situ. The lungs were then inflated with air and allowed to
stabilize at a distending pressure of 30 cm of water. This was
defined as maximum lung volume. The pressure was then
lowered by scheduled increments allowing ample time (1-2
min) for stabilization at each deflation pressure. The residual
volume at each pressure was recorded and expressed as a
percentage of maximum lung volume.
Collection ofsurfactant. The lungs were then lavaged five
times with a volume of saline equal to 75% of the maximum
lung volume. Specimens were considered unreliable and
discarded if <70% of the lavage fluid was recovered or they
were grossly contaminated with blood. The five washings from
each pup were pooled and centrifuged at 500 g for 5 min. The
supernate was collected and the lipid fraction was extracted
using two parts chloroform and one part methanol to one part
supernate. The aqueous phase was separated and removed,
and the lipid phase was washed with theoretical upper phase
(chloroform/methanol/water, 3:48:47, vol/vol/vol) (11). The
lipid extract was then stored at -20°C.
Glucose, ketone, and insulin assays. Serum glucose was
determined using the hexokinase-glucose-6-phosphate dehy-
drogenase reaction (Gluco Strate, General Diagnostics Warner
Lambert Co., Morris Plains, N. J.) (12). The presence of
ketones was semi-quantitatively determined using Acetest
reagent tablets (Ames Co., Elkhart, Ind.). One animal became
ketotic and was prospectively excluded. Serum insulin
concentrations were determined by double antibody radio-
immunoassay using iodinated porcine insulin and a purified
porcine insulin standard (13). The dose-response curves of
rabbit serum paralleled those produced by the purified
porcine insulin standard.
Phospholipid assay. The lipid extracts fromn the pups of
each litter were pooled. Total lipid phosphorus wvas
determined by the Bartlett technique (14). This spectropho-
tometric assay compared unknowns to a standard curve that
was linear between 3.3 and 48.4 nmol with a coefficient of
variation of +11% (n = 60).
A portion ofeach pooled specimen was reacted with osmium
tetroxide (Fisher Scientific Co., Pittsburgh, Pa.) by the
technique ofMason et al. (15). This technique has been demon-
strated to oxidize essentially all the phospholipids with
unsaturated fatty acid residues (16). Correction for DSPC loss
during oxidation was determined by the addition of trace
amounts of [14C]dipalmitoyl lecithin (New England Nuclear,
Boston, Mass.) to each specimen. The oxidized and unoxidized
fractions were separated by elution over an alumina column.
The amount of DSPC present in the unoxidized fraction was
below the lower limits of sensitivity of our phosphorus assay.
Therefore, the unoxidized fraction was evaporated under
nitrogen and the residue was resuspended in chloroform. Four
aliquots in two concentrations were applied to silica gel plates
impregnated with ammonium sulfate (Supelco, Inc., Bellefonte,
Pa.) and developed in chloroforn/methanol/ ammonia (70:30:3,
vol/vol). DSPC was visualized by charring (200°C for 30
min) and quantified using a dual beam reflectance densitom-
eter (Schoeffel I4nstruments Div., Kratos, Inc., Westwood, N.
J.). Quantities of DSPC were expressed as molar weights by
comparing densitometric areas to a standard curve. This curve
was generated using dipalmitoyl lecithin standard (Sigma
Chemical Co.) and is linear between 0.27 and 2.72 nmol. The
coefficient ofvariation of this standard curve is + 12% (n = 66),
comparable to that of the standard curve of the phosphorus
assay.
Phosphatidylglycerol (PG) was assayed by a modification of
the technique reported by Rooney et al. (17). An aliquot ofthe
pooled phospholipid fraction was spotted on ammonium sulfate
impregnated silica gel plates and developed three times to 10
cm in tetrahydrofuran/methylal/methanol/2 M ammonia (10:
8:2:1:1, vol/vol), with drying in a 70°C oven between each run.
The phospholipids were visualized by charring, and quantified
by reflectance densitometry as above. This techni(lue per-
mitted quantitation of as little as 0.26 nmol of PG.
Total lecithin/sphingomyelin (LUS) ratios were determined
by spotting an aliquot of the pooled phospholipid fraction on
ammonium sulfate impregnated silica gel plates. These were
developed in chloroform/methanol/water (65:25:4, vol/vol);
charred, and quantified by reflectance densitometry. Only the
L/S ratios were expressed as a ratio of densitometric areas.
Lavaged lungs were cleaned of all visible nonpulmonary
tissue, dried in a 50°C oven for 48 h, and weighed (18).
Statistics. In assessing the significance of differences in
fetal data sets, the number used was the number of litters and
the mean used was the mean ofthe average fetal value for each
litter (19). All values are reported as mean+SEM. Except
where noted, all statistical comparisons are done using the
Student's t test for unpaired variables.
RESULTS
The diabetic model. The 12 alloxan-treated non-
ketotic animals consistently showed clinical evidence
of glucose intolerance, i.e., polydypsia and polyuria,
but otherwise appeared healthy. The maternal serum
glucose and insulin at 21 and 28 d are depicted in Table
I. The mean serum glucose of treated animals was
significantly greater than that of the control animals.
Maternal serum insulin levels were similar at 21 d, but
were significantly lower in the treated animals at 28 d.
However, at both 21 and 28 d the glucose/insulin ratio
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TABLE I
Glucose, Insulin, and GlucoselInsulin Ratio in Maternal Rabbits
Glucose* Insulint Glucose/insulin*
Gestational period, d ......... 21 28 21 28 21 28
migldl p.U/,nl
Control 111.8 103.1 12.3 22.1 9.5 5.6
(n = 10) ±+13.2 +9.1 +2.9 ±1.2
Alloxan-treated 316.0 246.7 11.3 6.8 32.1 30.4
(n = 12) +32.2 +39.3 +7.5 +7.3
P value <0.001 <0.01 NS <0.01§ <0.02 <0.01
* Mean±SEM.
Median values.
§ Chi square analysis.
was significantly increased in treated does compared to
controls. This value reflects the secretory response of
the pancreas to serum glucose levels at single points in
time. Therefore, it appears that alloxan-treated does
were unable to respond to hyperglycemia with ex-
pected levels of insulin.
Fetal glucose levels were significantly elevated in
the pups of diabetic does (Table II), presumably a re-
flection of maternal hyperglycemia at the time of
sacrifice. Fetal insulin levels, however, did not vary
between the control and treated groups. Likewise, no
difference existed between fetal insulin levels from
litters ofmildly diabetic (28 d glucose < 200 mg/dl) and
severely diabetic (28 d glucose > 200 mg/dl) does
(53.8±9.6 vs. 49.1± 10.6 ,tU/ml). Glucose/insulin ratios,
however, were elevated in the fetuses of alloxan-
treated animals, suggesting that fetal hyperglycemia
did not elicit increased insulin secretion.
Fetuses of glucose-intolerant does did not demon-
strate tissue overgrowth. There were no sigriificant
differences between fetuses in control and alloxan-
treated litters in average body weight, crown-rump
length, placental weight, and weights of the liver,
lungs, heart, brain and kidneys, expressed as a
percentage of body weight (Table III).
TABLE II
Glucose, Inisulin, and GlucoselInsulin Ratio in Fetal Rabbits*
Glucose Insulin Glucose/insulin
mg/dl AUIlli
Control 65.8 48.1 1.6
(n = 10 litters) ±7.9 ±4.3 +0.4
Alloxan-treated 187.6 51.4 4.5
(it = 12 litters) ±37.4 ±6.8 ±1.0
P value <0.01 NS <0.05
* All values mean+SEM; 28-d gestation.
There were seven late gestation fetal deaths in the
treated litters and none in the control litters. Two major
congenital anomalies were observed, both in diabetic
pregnancies. One pup had a gastroschisis and the other
had arthrogryposis-like skeletal anomalies. Both of
these animals were prospectively excluded from the
study.
Pulmonary maturation. Results of pressure-volume
measurements are depicted in Fig. 1. Percentage of
retained air was significantly less in the treated litters at
0, 3, 5, 7, 10, and 15 cm H20. The absolute amount of
lavage DSPC was diminished in treated litters (154±41
nmol/g dry lung) compared with controls (248+61
nmol/g dry lung). However, the large amount of
variability in these values suggests the need for an
internal standard. Therefore, quantities of DSPC from
each litter were expressed as a percentage of the total
phospholipid phosphorus (nmol DSPC/nmol P x 100).
The percentage of DSPC in fluid from control litters
was significantly greater than the percentage of DSPC
in treated litters (38.0±4.3 vs. 20.5±4.2%; P < 0.01;
Fig. 2). The relationship between percent DSPC and
air retention on deflation at 10 cm H20 was similar for
both treated and control litters. This linear relationship
is illustrated in Fig. 3 by a common regression line
(r = 0.75, P < 0.01). A similar correlation was observed
at each of the deflation pressures from 0 to 15 cm H2O.
PG was not detected in any of the specimens and
therefore, ifpresent at all, represented <2% of the total
phospholipids. There was no significant difference
between the mean of the L/S ratios of tracheal lavage
fluid from fetuses of control (2.69±0.32) and alloxan-
treated (2.26±0.49) litters.
DISCUSSION
In this model for the diabetic pregnancy, premature
pups from glucose-intolerant does had significantly
altered pulmonary dynamics when compared to age-
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TABLE III
Fetal Growth Data*
Litter Fetal Crown-rump Placental Liver Lung Heart Brain Kidney
size wt length wt wt wt wt wt wt
g cm g % body wt
Control 7 33.42 8.5 3.29 6.38 3.09 0.55 2.64 0.92
(n = 10 litters) ±1 ±2.19 ±0.2 ±0.23 ±0.14 ±0.12 ±0.02 ±0.10 ±0.03
Alloxan-treated 8 28.65 8.1 3.09 6.57 3.15 0.55 2.65 0.85
(n = 12 litters) ±1 ±1.62 ±0.2 ±0.19 ±0.22 ±0.15 ±0.02 ±0.11 ±0.03
P value NS NS NS NS NS NS NS NS NS
* All values mean±SEM; 28-d gestation.
matched controls. Lungs of these animals retained less
air on deflation during pressure-volume measure-
ments. DSPC represented a lesser portion of the total
pulmonary lavage phospholipids in fetuses of hyper-
glycemic animals, and the percentage of DSPC varied
directly with retained air on lung deflation. These
findings indicate that matemal glucose intolerance is
associated with significant alterations in fetal pul-
monary development.
It is unlikely that the observed changes in pulmonary
dynamics and phospholipid metabolism resulted from
the effect of alloxan on the fetal animal. In the rabbit,
ovulation occurs after mating, and fertilization does not
occur until 12 h later. Implantation ofthe ova is delayed
until 7 d of gestation (20). Since the serum half-life of
alloxan is <1 min (21), the drug would either be metabo-
lized or entirely tissue-bound within 60 h of fertiliza-
tion and several days before implantation, long before
pancreatic (22) or pulmonary (23) tissue differentiation.
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cross the placenta, even diabetogenic maternal doses
given later in gestation do not cause diabetes in
offspring (24). The observed effects on the fetal rabbits
then, may be assumed to be a result of influences other
than alloxan on the fetal milieu.
Pulmonary stability assessed by measurement of
pressure-volume relationships has been proposed as a
functional index of fetal pulmonary maturity. Increased
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FIGURE 1 Mean pressure-volume data for fetuses of control
(n = 10) and alloxan-treated (n = 12) litters. Lung volume on
deflation is expressed as percentage ofmaximum lung volume.
The fetuses of alloxan-treated does had significantly less
retention of air at 0, 3, 5, 7, 10, and 15 cm H20 pressure
(*P < 0.05, **p < 0.01).
FIGURE 2 DSPC in pulmonary lavage expressed as per-
centage of total phospholipid phosphorus in control and
alloxan-treated litters. The value of the pooled lavage specimen
from each litter is illustrated as well as the mean±SEM ofeach
group. The difference between the control and alloxan-treated
means is significant (P < 0.01; n = 22).





















FIGURE 3 Relationship between percer
monary lavage and the percentage of ma
retained at a deflation pressure of 10 c
regression lines illustrate this relation
alloxan-treated litters. These are not si
The linear correlation for all litters is ill
line and is significant (r = 0.75; P < 0.0
older fetal animals (25, 26) and is o
with accelerated pulmonary matui
exogenous steroids (10, 27). By conti
who succumb with RDS have dimii
deflation (28). Our finding that air re
in fetuses of glucose-intolerant doe
findings reported by Sosenko an
Differences in pulmonary air retentii
are presumed to be a result of altern
forces and not changes in tissue eL
fetal lamb, increased quantities
material from alveolar washings ha)
with greater stability on deflation
increased air retention occurs co
histologic appearance of increasing
alveolar cells with osmiophilic lar
intracellular storage form of surfactant (25). These
findings suggest that reduced alveolar surfactant is the
principal cause of diminished air retention in the
_ ° o ' fetuses of alloxan-treated litters.
Alveolar surfactant is composed of a mixture of phos-
- ~ * pholipids and at least one immunospecific protein.
DSPC is the phospholipid present in highest con-
o centration in pulmonary surfactant (7) and has the
capacity to reduce surface tension and stabilize alveoli
on deflation in the newborn lung (6). Phospholipids
ONTROL recovered by pulmonary lavage reflect those secreted
LLOXAN-TREATED into the alveolus. We assume that DSPC is removed by
lavage with efficiency similar to all other alveolar
40 50 60 phospholipids. However, absolute recovery of phos-
pholipids may vary between and within litters. There-
fore, quantities of DSPC are expressed as a percentage
itage of DSPC in pul- of total lavage phospholipids. This manner of expres-iximum lung volume
m H20. The broken sion tends to reduce variance induced by differences in
ship for control and recovery and has been used by other investigators
ignificantly different. when certainty about complete recovery is in doubt (29).
lustrated by the solid Percent DSPC in lavage fluid was significantly
11; n = 22). reduced in fetuses of glucose-intolerant does compared
to controls (P < 0.01; two-tailed t test). It may be
)bserved in fetuses argued that the reduced ratio in treated litters is due to
ration induced by change in either the DSPC value or the total
rast, human infants phospholipid value. Table IV7 demonstrates the
nished stability on absolute values for DSPC and total phospholipids
Atention is reduced (nmol/g dry lung) found in control and treated litters.
s is comparable to The control DSPC value is 61% greater than the treated
id co-workers (9). DSPC value, whereas the control total phospholipid
on at low pressures value is 18% less than the value for treated litters.
ed alveolar surface Evaluation of the distribution of absolute DSPC and
isticity (26). In the phospholipid values about their respective medians
of surface-active suggests that DSPC values in treated litters are lower
ve been associated than in controls (P < 0.05; x2; one-tailed), whereas
(25). In addition, phospholipid values in treated and control litters are
incident with the evenly distributed around their median. Therefore, we
numbers of large conclude that the difference observed in the percent
mellar bodies, the DSPC in treated and control litters is primarily due to
TABLE IV
Lavage Phospholipid Values
DSPC Total phospholipid Percenit DSPC
Alloxan- Alloxan- Alloxan-
Control treated Control treated Control treated
niny1ollg dry lulig unoig dIry lutng
Bose et al. Mean 248 154 608 737 38.0 20.5
(current study) SEM 61 41 111 115 4.3 4.2
P < 0.05* NS P < 0.01
Sosenko et al. Mean 75 60 - -
SEM 23 27
NS
* One-tailed chi square.
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change in the DSPC value. On the other hand, Sosenko
et al. (9) did not find a significant difference between
absolute DSPC values in five control and five treated
litters (Table IV). Their failure to find a significant
difference may be solely due to the large variance about
the mean. The reason for the large disparity between
the absolute DSPC values of Sosenko et al. and those of
the present study is unknown, but probably due to
technical differences between the two studies. Quanti-
ties of lavage phospholipids in 28-d control fetuses
observed in the present study are similar to those
reported (30, 31).
PG has also been shown to have surface-active proper-
ties (32), and its absence has been implicated by some
investigators in the etiology ofRDS in the IDM (33). PG
was not detected in lavage fluid from either treated or
control litters. Likewise, the L/S ratios were similar in
treated and control litters. The diminished levels of
DSPC observed in lavage fluid from treated litters and
the positive correlation between retention of air and
percent DSPC therefore suggest that the alterations in
the physical properties of the fetal lungs may be
entirely a result of diminished concentrations of
alveolar DSPC. Although the mechanismn for this
diminution remains unclear, we postulate that the
delayed functional development of surfactant observed
in many IDM may be due to diminished alveolar
concentrations of DSPC.
Several investigators have used in vitro models to
study the manner by which the diabetic milieu exerts
its effect on phospholipid metabolism. Smith et al. (34)
examined the rate ofcholine incorporation into lecithin
in type II pneumonocytes in cell culture under the
influence of insulin and cortisol. They found that
insulin inhibited the stimulatory effect of cortisol on
lecithin synthesis. This finding implies that the
hyperinsulinemia observed in IDM (35) inhibits the
effect ofendogenous corticosteroids on fetal pulmonary
lecithin synthesis. Similarly, Gross and Smith (36)
demonstrated delayed morphologic maturation of type
II cells and delayed appearance oflamellar osmiophilic
bodies in the presence ofhigh insulin levels in rat lung
organ culture. In this study fetuses of treated animals
did not demonstrate hyperinsulinism. Fetal serum
glucose levels, however, were elevated at the time of
sacrifice; and since maternal glucose levels were sig-
nificantly elevated earlier in gestation, it is presumed that
fetal hyperglycemia was relatively long standing.
Therefore, the diminished levels of DSPC observed in
alloxan-treated litters may be due to the effects of
hyperglycemia rather than alterations in insulin levels.
This hypothesis is supported by the recent report of
Sosenko et al. (37) who found that cord blood levels ofC-
peptide, the by-product of the cleavage of proinsulin to
insulin, were increased in IDM who were macrosomic
or had postnatal hypoglycemia. However, they found
no correlation between cord blood C-peptide alnd the
presence of RDS in the IDM.
Assessment of fetal pulmonary phospholipid synthesis
has been approximiated by measurement of surfactant
components in amniotic fluid (16, 38). If; as we
postulate, the delay in pulmonary matturation in IDM is
a result of diminished alveolar concentrations ofDSPC,
this diminution miay be reflected in amniotic fluid.
Measurement ofamniotic fluid DSPC might then prove
to be a better predictor of pulmonary maturation in the
diabetic pregnancy.
Our rabbit model of diabetes during pregnancy has
several features in common with those observed in the
human diabetic pregnancy: matemal and fetal hyper-
glycemia, maternal insulinopenia, fetal pulmonary
instability on deflation consistent with RDS, and an
apparent increased incidence of congenital anomalies
and fetal wvastage. The fetuses of diabetic does, how-
ever, did not demonstrate hyperinsulinism or over-
growth. These particular inconsistencies have l)een
reported by other investigators in subprimate models of
the diabetic pregnancy (39-41). The fact that glucose is
not a potent insulin secretogogue during fetal life (42)
may explain the lack of hyperinsulinism in the fetuses
of the alloxan-treated does. Since the gestation of the
rabbit is short and since rabbit pups are born before a
gestational period of rapid growth, compiarable to the
third trimester of human gestation, it is possible that
there is insufficient time during gestation for fetal
overgrowth to occur. Nonetheless, this model of the
diabetic pregnancy appears to be a useful and practical
model with which to study the effects of maternal
diabetes on pulmonary maturation in the fetus.
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